|
myotonic dystrophy type 1
|
DOID_11722 |
|
|
myotonic disease
|
DOID_450 |
|
|
distal myopathy
|
DOID_11720 |
|
|
panel-assay profile endpoint
|
BAO_0002139 |
|
|
Lyme disease
|
DOID_11729 |
|
|
facioscapulohumeral muscular dystrophy
|
DOID_11727 |
|
|
myositis ossificans
|
DOID_668 |
|
|
Emery-Dreifuss muscular dystrophy
|
DOID_11726 |
|
|
Cornelia de Lange syndrome
|
DOID_11725 |
|
|
limb-girdle muscular dystrophy
|
DOID_11724 |
|
|
logP
|
BAO_0002130 |
|
|
pKa
|
BAO_0002131 |
|
|
percent purity
|
BAO_0002132 |
|
|
apical‑to‑basolateral permeability (A > B)
|
BAO_0002133 |
|
|
basolateral‑to‑apical permeability (B > A)
|
BAO_0002134 |
|
|
adrenal cortex cancer
|
DOID_660 |
|
|
gyrate atrophy
|
DOID_1415 |
|
|
narcissistic personality disorder
|
DOID_2745 |
|
|
mitochondrial membrane potential assay
|
BAO_0002190 |
|
|
assay footprint
|
BAO_0000512 |
|
